Request For Public Comment: 60-Day Proposed Information Collection: Indian Health Service Medical Staff Credentials And Privileges Files, 19721-19723 [2013-07596]
Download as PDF
srobinson on DSK4SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 63 / Tuesday, April 2, 2013 / Notices
Pharmacology and Therapeutics,
78(6):689–96, 2005.
2. Benowitz, N.L., et al., ‘‘Suppression of
Nicotine Intake During Ad Libitum
Cigarette Smoking by High-Dose
Transdermal Nicotine,’’ Journal of
Pharmacology and Experimental
Therapeutics, 287(3):958–62, 1998.
3. Blondal, T., et al., ‘‘Nicotine Nasal Spray
With Nicotine Patch for Smoking
Cessation: Randomised Trial With Six
Year Follow Up,’’ BMJ, 318(7179):285–8,
1999.
4. Bohadana, A., et al., ‘‘Nicotine Inhaler and
Nicotine Patch as a Combination
Therapy for Smoking Cessation,’’
Archives of Internal Medicine,
160(20):3128–34, 2000.
5. Bolliger, C.T., et al, ‘‘Smoking Reduction
With Oral Nicotine Inhalers: Double
Blind, Randomised Clinical Trial of
Efficacy And Safety,’’ BMJ,
321(7257):329–33, 2000.
6. Bullen, C., et al., ‘‘Precessation Nicotine
Replacement Therapy: Pragmatic
Randomized Trial,’’ Addiction,
105(8):1474–83, 2010.
7. Dale, L.C., et al., ‘‘High-Dose Nicotine
Patch Therapy. Percentage of
Replacement and Smoking Cessation,’’
JAMA, 274(17):1353–58, 1995.
8. Etter, J.F., et al., ‘‘Nicotine Replacement to
Reduce Cigarette Consumption in
Smokers Who Are Unwilling to Quit: A
Randomized Trial,’’ Journal of Clinical
Psychopharmacology, 22(5):487–95,
2002.
9. Etter, J.F., et al., ‘‘Postintervention Effect
of Nicotine Replacement Therapy on
Smoking Reduction in Smokers Who Are
Unwilling to Quit: A Randomized Trial,’’
Journal of Clinical Psychopharmacology,
24(2):174–79, 2004.
10. Etter, J.F., et al., ‘‘Nicotine Gum
Treatment Before Smoking Cessation—A
Randomized Trial,’’ Archives of Internal
Medicine, 169(11):1028–34, 2009.
11. Hajek, P., et al., ‘‘Dependence Potential of
Nicotine Replacement Treatments:
Effects of Product Type, Patient
Characteristics, and Cost to User,’’
Preventive Medicine, 44(3):230–34, 2007.
12. Hall, S.M., et al., ‘‘Extended Treatment of
Older Cigarette Smokers,’’ Addiction,
104(6):1043–52, 2009.
13. Hatsukami, D., et al., ‘‘Effects of High
Dose Transdermal Nicotine Replacement
in Cigarette Smokers,’’ Pharmacology,
Biochemistry, and Behavior, 86(1):132–
39, 2007.
14. Horst, W.D., et al., ‘‘Extended Use of
Nicotine Replacement Therapy to
Maintain Smoking Cessation in Persons
With Schizophrenia,’’ Neuropsychiatric
Disease and Treatment, 1(4):349–55,
2005.
15. Houtsmuller, E.J., et al., ‘‘Flavor
Improvement Does Not Increase Abuse
Liability of Nicotine Chewing Gum,’’
Pharmacology, Biochemistry, and
Behavior, 72(3):559–68, 2002.
16. Hughes, J.R., et al., ‘‘A Randomized,
Controlled Trial of NRT-Aided Gradual
Vs. Abrupt Cessation in Smokers
Actively Trying to Quit,’’ Drug and
Alcohol Dependence, 111(1–2):105–13,
VerDate Mar<15>2010
19:35 Apr 01, 2013
Jkt 229001
2010.
17. Joseph, A.M., et al., ‘‘Chronic Disease
Management for Tobacco Dependence,’’
Archives of Internal Medicine,
171(21):1894–1900, 2011.
18. Lerman, C., et al., ‘‘Genetic Variation in
Nicotine Metabolism Predicts the
Efficacy of Extended-Duration
Transdermal Nicotine Therapy,’’ Clinical
Pharmacology and Therapeutics,
87(5):553–57, 2010.
19. Lindson, N. and Aveyard, P., ‘‘An
Updated Meta-Analysis of Nicotine
Preloading for Smoking Cessation:
Investigating Mediators of the Effect,’’
Psychopharmacology, 214(3):579–92,
2011.
20. Murray, R.P., et al., ‘‘Safety of Nicotine
Polacrilex Gum Used by 3,094
Participants in the Lung Health Study.
Lung Health Study Research Group,’’
CHEST, 109(2):438–45, 1996.
21. Murray, R.P., et al., ‘‘Does Nicotine
Replacement Therapy Cause Cancer?
Evidence From the Lung Health Study,’’
Nicotine & Tobacco Research,
11(9):1076–82, 2009.
22. Newhouse, P., et al., ‘‘Nicotine Treatment
of Mild Cognitive Impairment: A 6Month Double-Blind Pilot Clinical
Trial,’’ Neurology, 78(2):91–101, 2012.
23. Piper, M.E., et al., ‘‘A Randomized
Placebo-Controlled Clinical Trial of 5
Smoking Cessation Pharmacotherapies,’’
Archives of General Psychiatry,
66(11):1253–62, 2009.
24. Rennard, S.I., et al., ‘‘Efficacy of the
Nicotine Inhaler in Smoking Reduction:
A Double-Blind, Randomized Trial,’’
Nicotine & Tobacco Research, 8(4):555–
64, 2006.
25. Rose, J.E., et al., ‘‘Mecamylamine
Combined With Nicotine Skin Patch
Facilitates Smoking Cessation Beyond
Nicotine Patch Treatment Alone,’’
Clinical Pharmacology and
Therapeutics, 56(1):86–99, 1994.
26. Rose, J.E., et al., ‘‘Nicotinemecamylamine Treatment for Smoking
Cessation: The Role of Precessation
Therapy,’’ Experimental and Clinical
Psychopharmacology, 6(3):331–43, 1998.
27. Rose, J.E., et al., ‘‘Precessation Treatment
With Nicotine Skin Patch Facilitates
Smoking Cessation,’’ Nicotine & Tobacco
Research, 8(1):89–101, 2006.
28. Rose, J.E., et al., ‘‘Precessation Treatment
With Nicotine Patch Significantly
Increases Abstinence Rates Relative to
Conventional Treatment,’’ Nicotine &
Tobacco Research, 11(9):1067–75, 2009.
29. Schuurmans, M.M., et al., ‘‘Effect of
Pretreatment With Nicotine Patch on
Withdrawal Symptoms and Abstinence
Rates in Smokers Subsequently Quitting
With the Nicotine Patch: A Randomized
Controlled Trial,’’ Addiction, 99(5):634–
40, 2004.
30. T2010
19:35 Apr 01, 2013
Jkt 229001
out an agency function; (b) whether the
agency processes the information
collected in a useful and timely fashion;
(c) the accuracy of public burden
estimate (the estimated amount of time
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
needed for individual respondents to
provide the requested information); (d)
whether the methodology and
assumptions used to determine the
estimate is logical; (e) ways to enhance
E:\FR\FM\02APN1.SGM
02APN1
19723
Federal Register / Vol. 78, No. 63 / Tuesday, April 2, 2013 / Notices
the quality, utility, and clarity of the
information being collected; and (f)
ways to minimize the public burden
through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Send Comments and Requests for
Further Information: For the proposed
collection or requests to obtain a copy
of the data collection instrument(s) and
instructions to: Paul R. Fowler D.O.,
J.D., Risk Management Officer, 801
Thompson Avenue, TMP, Suite 331,
Rockville, MD 20852, call non-toll free
(301) 443–6372, send via facsimile to
(301) 594–6213, or send your email
requests, comments, and return address
to: paul.fowler@ihs.gov.
Comment Due Date: Your comments
regarding this information collection is
best assured of having full effect if
received within 60 days of the date of
this publication.
Dated: March 26, 2013.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2013–07596 Filed 4–1–13; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Evaluation of the Brain
Disorders in the Developing World
Program of the John E. Fogarty
International Center
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
John E. Fogarty International Center,
National Institutes of Health (NIH), will
publish periodic summaries of proposed
SUMMARY:
International Center (FIC), National
Institutes of Health (NIH).
Need and Use of Information
Collection: This study seeks to evaluate
the management, effectiveness, and
outcomes of the Brain Disorders in the
Developing World extramural research
program administered by the John E.
Fogarty International Center of the NIH.
The purpose of the Brain Disorders in
the Developing World Program is to
develop collaborative research and
capacity building projects on brain
disorders throughout life relevant to
low- and middle-income countries.
Awardees are expected to develop
innovative projects that contribute to
the long-term goal of building
sustainable research capacity in nervous
system function and impairment
throughout life. Between FY 2003 and
2012, a total of 132 awards were made
under the Brain Disorders program, and
the total investment by Fogarty and its
partners at NIH has been approximately
$75 million. The findings of this
evaluation study will provide valuable
information concerning: (1) Whether
and how the program has met its goal
of supporting research and research
capacity-building on brain disorders in
low- and middle-income countries; (2)
the extent to which the program as
implemented functions efficiently and
effectively; (3) the extent to which the
program is consistent with the strategic
priorities of Fogarty and its partners at
NIH; (4) opportunities to improve upon
the current implementation of the
program if NIH chooses to continue
supporting it; and (5) models, best
practices, and lessons learned that may
be applicable to other NIH programs,
now and in the future.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 151.
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Dr. Rachel Sturke,
Fogarty International Center, National
Institutes of Health, 16 Center Drive,
Building 16, Room 202, Bethesda, MD
20892, or call non-toll-free number 301–
496–1491, or Email your request,
including your address to:
sturkerachel@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Evaluation of the
Brain Disorders in the Developing
World Program of the John E. Fogarty
International Center, 0925–New, Fogarty
ESTIMATED ANNUALIZED BURDEN HOURS
srobinson on DSK4SPTVN1PROD with NOTICES
Awardee Interviews (LMIC) ..............................................
Awardee Interviews (US) ..................................................
Trainee Interviews .............................................................
Awardee Survey (LMIC) ...................................................
Awardee Survey (US) .......................................................
VerDate Mar<15>2010
19:35 Apr 01, 2013
Jkt 229001
Number
of respondents
Type of
respondent
Form name
PO 00000
Researchers
Researchers
Researchers
Researchers
Researchers
Frm 00087
Fmt 4703
Number of
responses per
respondent
30
30
15
115
114
1
1
1
1
1
.....
.....
.....
.....
.....
Sfmt 4703
E:\FR\FM\02APN1.SGM
02APN1
Average
burden per
response
(in hours)
1
1
1
20/60
20/60
Total annual
burden hour
30
30
15
38
38
Agencies
[Federal Register Volume 78, Number 63 (Tuesday, April 2, 2013)]
[Notices]
[Pages 19721-19723]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07596]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Request For Public Comment: 60-Day Proposed Information
Collection: Indian Health Service Medical Staff Credentials And
Privileges Files
AGENCY: Indian Health Service, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3506(c)(2)(A) of the Paperwork
[[Page 19722]]
Reduction Act of 1995 which requires 60 days for public comment on
proposed information collection projects, the Indian Health Service
(IHS) is publishing for comment a summary of a proposed information
collection to be submitted to the Office of Management and Budget (OMB)
for review.
Proposed Collection
Title: 0917-0009, ``Indian Health Service Medical Staff Credentials
and Privileges Files.'' Type of Information Collection Request:
Extension, without revision, of currently approved information
collection, 0917-0009, ``Indian Health Service Medical Staff
Credentials and Privileges Files.'' Form Numbers: 0917-0009. Need and
Use of Information Collection: This collection of information is used
to evaluate individual health care providers applying for medical staff
privileges at IHS health care facilities. The IHS operates health care
facilities that provide health care services to American Indians and
Alaska Natives. To provide these services, the IHS employs (directly
and under contract) several categories of health care providers
including: Physicians (M.D. and D.O.), dentists, psychologists,
optometrists, podiatrists, audiologists, physician assistants,
certified registered nurse anesthetists, nurse practitioners, and
certified nurse midwives. IHS policy specifically requires physicians
and dentists to be members of the health care facility medical staff
where they practice. Health care providers become medical staff
members, depending on the local health care facility's capabilities and
medical staff bylaws. There are three types of IHS medical staff
applicants: (1) Health care providers applying for direct employment
with IHS; (2) contractors who will not seek to become IHS employees;
and (3) employed IHS health care providers who seek to transfer between
IHS health care facilities.
National health care standards developed by the Centers for
Medicare and Medicaid Services, the Joint Commission, and other
accrediting organizations require health care facilities to review,
evaluate and verify the credentials, training and experience of medical
staff applicants prior to granting medical staff privileges. In order
to meet these standards, IHS health care facilities require all medical
staff applicants to provide information concerning their education,
training, licensure, and work experience and any adverse disciplinary
actions taken against them. This information is then verified with
references supplied by the applicant and may include: former employers,
educational institutions, licensure and certification boards, the
American Medical Association, the Federation of State Medical Boards,
the National Practitioner Data Bank, and the applicants themselves.
In addition to the initial granting of medical staff membership and
clinical privileges, the Joint Commission standards require that a
review of the medical staff be conducted not less than every two years.
This review evaluates the current competence of the medical staff and
verifies whether they are maintaining the licensure or certification
requirements of their specialty.
The medical staff credentials and privileges records are maintained
at the health care facility where the health care provider is a medical
staff member. The establishment of these records at IHS health care
facilities is a Joint Commission requirement. Prior to the
establishment of this Joint Commission requirement, the degree to which
medical staff applications were maintained at all health care
facilities in the United States that are verified for completeness and
accuracy varied greatly across the Nation.
The application process has been streamlined and is using
information technology to make the application electronically available
on the Internet. The application may be found at the IHS.gov Web site
address: https://www.ihs.gov/IHM/index.cfm?module=dsp_ihm_pc_p3c1_ex#Manual Exhibit 3-1-A.
Affected Public: Individuals and households. Type of Respondents:
Individuals.
The table below provides: Types of data collection instruments,
Estimated number of respondents, Number of annual number of responses,
Average burden per response, and Total annual burden hours.
----------------------------------------------------------------------------------------------------------------
Estimated
Data collection instrument(s) number of Responses per Average burden hour per Total annual
respondents Respondent response* burden hours
----------------------------------------------------------------------------------------------------------------
Application to Medical Staff....... 570 1 1.00 (60 mins)............. 570
Reference Letter................... 1710 1 0.33 (20 mins)............. 570
Reappointment Request.............. 190 1 1.00 (60 mins)............. 190
Ob-Gyn Privileges.................. 20 1 1.00 (60 mins)............. 20
Internal Medicine.................. 325 1 1.00 (60 mins)............. 325
Surgery Privileges................. 20 1 1.00 (60 mins)............. 20
Psychiatry Privileges.............. 13 1 1.00 (60 mins)............. 13
Anesthesia Privileges.............. 15 1 1.00 (60 mins)............. 15
Dental Privileges.................. 150 1 0.33 (20 mins)............. 50
Optometry Privileges............... 21 1 0.33 (20 mins)............. 7
Psychology Privileges.............. 30 1 0.17 (10 mins)............. 5
Audiology Privileges............... 7 1 0.08 (5 mins).............. 1
Podiatry Privileges................ 7 1 0.08 (5 mins).............. 1
Radiology Privileges............... 8 1 0.33 (20 mins)............. 3
Pathology Privileges............... 3 1 0.33 (20 mins)............. 1
----------------------------------------------------------------------------
Total.......................... 3,089 .............. ........................... 1,791
----------------------------------------------------------------------------------------------------------------
* For ease of understanding, burden hours are provided in actual minutes.
There are no capital costs, operating costs and/or maintenance costs to respondents.
Request for Comments: Your written comments and/or suggestions are
invited on one or more of the following points: (a) Whether the
information collection activity is necessary to carry out an agency
function; (b) whether the agency processes the information collected in
a useful and timely fashion; (c) the accuracy of public burden estimate
(the estimated amount of time needed for individual respondents to
provide the requested information); (d) whether the methodology and
assumptions used to determine the estimate is logical; (e) ways to
enhance
[[Page 19723]]
the quality, utility, and clarity of the information being collected;
and (f) ways to minimize the public burden through the use of
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology.
Send Comments and Requests for Further Information: For the
proposed collection or requests to obtain a copy of the data collection
instrument(s) and instructions to: Paul R. Fowler D.O., J.D., Risk
Management Officer, 801 Thompson Avenue, TMP, Suite 331, Rockville, MD
20852, call non-toll free (301) 443-6372, send via facsimile to (301)
594-6213, or send your email requests, comments, and return address to:
paul.fowler@ihs.gov.
Comment Due Date: Your comments regarding this information
collection is best assured of having full effect if received within 60
days of the date of this publication.
Dated: March 26, 2013.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2013-07596 Filed 4-1-13; 8:45 am]
BILLING CODE 4165-16-P